Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

NCT03685890 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

74

Enrollment

OTHER_GOV

Sponsor class

Conditions

Melanoma
In-Transit Metastasis

Interventions

DRUG: Nivolumab
PROCEDURE: Isolated limb perfusion (ILP)

Sponsor

Vastra Gotaland Region